{
  "trial_id": "NCT00329030",
  "trial_group": "cancer",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, gender, diagnosis, CD20 status, number of prior chemotherapy regimens, disease status, bone marrow involvement percentage, cardiac function (left ventricular ejection fraction), hepatic function (bilirubin, ALT, AST levels), renal function (creatinine, creatinine clearance), pulmonary function (DLCO, FEV1, FVC), CD34+ cell count in autologous graft, Karnofsky performance score, prior malignancies, HIV status, pregnancy status, prior autologous or allogeneic HSCT, evidence of MDS/AML, prior severe reaction to Rituxan or Filgrastim, prior radioimmunotherapy, hypersensitivity to murine proteins.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "gender"
        ],
        [
          "Karnofsky Performance-status Score",
          "Karnofsky performance score"
        ],
        [
          "Number of Prior Therapies",
          "number of prior chemotherapy regimens"
        ],
        [
          "Disease Status at Transplantation",
          "disease status"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)",
        "Primary Disease Stage"
      ],
      "remaining_candidate_features": [
        "diagnosis",
        "CD20 status",
        "bone marrow involvement percentage",
        "cardiac function (left ventricular ejection fraction)",
        "hepatic function (bilirubin, ALT, AST levels)",
        "renal function (creatinine, creatinine clearance)",
        "pulmonary function (DLCO, FEV1, FVC)",
        "CD34+ cell count in autologous graft",
        "prior malignancies",
        "HIV status",
        "pregnancy status",
        "prior autologous or allogeneic HSCT",
        "evidence of MDS/AML",
        "prior severe reaction to Rituxan or Filgrastim",
        "prior radioimmunotherapy",
        "hypersensitivity to murine proteins"
      ]
    }
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Disease status at baseline, Number of prior chemotherapy regimens, Bone marrow involvement percentage, Cardiac function (e.g., left ventricular ejection fraction), Hepatic function (e.g., bilirubin, ALT, AST levels), Renal function (e.g., creatinine, creatinine clearance), Pulmonary function (e.g., DLCO, FEV1, FVC), CD34+ cell count in autologous graft, Karnofsky performance score,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Karnofsky Performance-status Score",
          "Karnofsky performance score"
        ],
        [
          "Number of Prior Therapies",
          "Number of prior chemotherapy regimens"
        ]
      ],
      "remaining_reference_features": [
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)",
        "Primary Disease Stage",
        "Disease Status at Transplantation"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Region of Enrollment",
        "Disease status at baseline",
        "Bone marrow involvement percentage",
        "Cardiac function (e.g., left ventricular ejection fraction)",
        "Hepatic function (e.g., bilirubin, ALT, AST levels)",
        "Renal function (e.g., creatinine, creatinine clearance)",
        "Pulmonary function (e.g., DLCO, FEV1, FVC)",
        "CD34+ cell count in autologous graft"
      ]
    }
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Karnofsky Performance Status, CD20 Status, Bone Marrow Involvement, Prior Chemotherapy Regimens, Disease Status, Left Ventricular Ejection Fraction, Bilirubin, Alanine Transaminase, Aspartate Transaminase, Creatinine, Creatinine Clearance, Carbon Monoxide Diffusing Capacity, FEV1, FVC, CD34+ Cell Dose.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Karnofsky Performance-status Score",
          "Karnofsky Performance Status"
        ],
        [
          "Number of Prior Therapies",
          "Prior Chemotherapy Regimens"
        ],
        [
          "Disease Status at Transplantation",
          "Disease Status"
        ]
      ],
      "remaining_reference_features": [
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)",
        "Primary Disease Stage"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Region of Enrollment",
        "CD20 Status",
        "Bone Marrow Involvement",
        "Left Ventricular Ejection Fraction",
        "Bilirubin",
        "Alanine Transaminase",
        "Aspartate Transaminase",
        "Creatinine",
        "Creatinine Clearance",
        "Carbon Monoxide Diffusing Capacity",
        "FEV1",
        "FVC",
        "CD34+ Cell Dose"
      ]
    }
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, Karnofsky performance score, diagnosis (REAL classification), CD20 status, prior chemotherapy regimens, disease status, bone marrow involvement, cardiac function (American Heart Association Class, left ventricular ejection fraction), hepatic function (bilirubin, ALT, AST), renal function (creatinine, creatinine clearance), pulmonary function (DLCO, FEV1, FVC), autologous graft characteristics (CD34+ cells/kg).",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race (NIH/OMB)",
          "race"
        ],
        [
          "Karnofsky Performance-status Score",
          "Karnofsky performance score"
        ],
        [
          "Primary Disease Stage",
          "diagnosis (REAL classification)"
        ],
        [
          "Disease Status at Transplantation",
          "disease status"
        ],
        [
          "Number of Prior Therapies",
          "prior chemotherapy regimens"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Ethnicity (NIH/OMB)"
      ],
      "remaining_candidate_features": [
        "CD20 status",
        "bone marrow involvement",
        "cardiac function (American Heart Association Class, left ventricular ejection fraction)",
        "hepatic function (bilirubin, ALT, AST)",
        "renal function (creatinine, creatinine clearance)",
        "pulmonary function (DLCO, FEV1, FVC)",
        "autologous graft characteristics (CD34+ cells/kg)"
      ]
    }
  }
}